ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

In Brief: Sondik is Acting NCI Deputy Director; $21 mil. Gift Supports Univ. Of Chicago

March 4, 1994

Schweiker Approves Transfer Of NTP’s NNCI Contribution To NIESH In FY’83

July 31, 1981

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

“Mini-Transplantation” In Testing For Treatment Of Multiple Myeloma

January 25, 2002

PDQ Out of Business Of Setting Guidelines For Cancer Screening

September 17, 1993